Aptose Biosciences Inc.

General ticker "APTO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.4M (TTM average)

Aptose Biosciences Inc. does not follow the US Stock Market performance with the rate: -28.6%.

Estimated limits based on current volatility of 7.1%: low 2.01$, high 2.32$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.43$, 6.19$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.84$, 3.38$]

Financial Metrics affecting the APTO estimates:

  • Negative: Non-GAAP EPS, $ of -89.18 <= 0.04
  • Negative: Shareholder equity ratio, % of -44.86 <= 22.52
  • Negative: Operating cash flow per share per price, % of -0.85 <= 1.79
  • Positive: Interest expense per share, $ of 0 <= 0.10
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -27.42 <= 0
  • Positive: -0.07 < Operating profit margin, % of 0
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term APTO quotes

Long-term APTO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $42.60MM $52.36MM $0.00MM
Operating Income $-42.60MM $-52.36MM $0.00MM
Non-Operating Income $0.78MM $1.15MM $-25.43MM
Interest Expense $0.00MM $0.00MM $0.21MM
R&D Expense $28.09MM $36.77MM $15.10MM
Income(Loss) $-41.82MM $-51.21MM $-25.43MM
Profit(Loss)* $-41.82MM $-51.21MM $-25.43MM
Stockholders Equity $37.74MM $-2.90MM $-4.54MM
Assets $51.03MM $12.99MM $10.13MM
Operating Cash Flow $-32.32MM $-44.59MM $-35.98MM
Capital expenditure $0.02MM $0.03MM $0.01MM
Investing Cash Flow $30.07MM $9.96MM $0.02MM
Financing Cash Flow $0.12MM $6.91MM $33.41MM
Earnings Per Share** $-6.80 $-7.58 $-0.04

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.